Xencor, Inc. (XNCR)
24.72
+0.13
(+0.53%)
USD |
NASDAQ |
Sep 18, 16:00
24.72
0.00 (0.00%)
After-Hours: 20:00
Xencor Free Cash Flow : -208.28M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -208.28M |
| March 31, 2026 | -188.84M |
| December 31, 2025 | -138.27M |
| September 30, 2025 | -137.94M |
| June 30, 2025 | -135.08M |
| March 31, 2025 | -167.31M |
| December 31, 2024 | -205.96M |
| September 30, 2024 | 26.06M |
| June 30, 2024 | 23.50M |
| March 31, 2024 | 49.34M |
| December 31, 2023 | 63.86M |
| September 30, 2023 | -150.97M |
| June 30, 2023 | -136.30M |
| March 31, 2023 | -63.54M |
| December 31, 2022 | -18.92M |
| September 30, 2022 | 71.55M |
| June 30, 2022 | 44.79M |
| March 31, 2022 | 1.975M |
| December 31, 2021 | -32.83M |
| September 30, 2021 | -75.12M |
| June 30, 2021 | -41.57M |
| March 31, 2021 | -57.61M |
| December 31, 2020 | -18.77M |
| September 30, 2020 | -54.86M |
| Date | Value |
|---|---|
| June 30, 2020 | -55.44M |
| March 31, 2020 | 80.38M |
| December 31, 2019 | 53.34M |
| September 30, 2019 | 56.38M |
| June 30, 2019 | 54.46M |
| March 31, 2019 | -82.12M |
| December 31, 2018 | -88.90M |
| September 30, 2018 | -77.29M |
| June 30, 2018 | -72.07M |
| March 31, 2018 | -56.11M |
| December 31, 2017 | -40.88M |
| September 30, 2017 | -48.64M |
| June 30, 2017 | 90.76M |
| March 31, 2017 | 94.83M |
| December 31, 2016 | 91.61M |
| September 30, 2016 | 103.39M |
| June 30, 2016 | 9.107M |
| March 31, 2016 | 11.27M |
| December 31, 2015 | 22.99M |
| September 30, 2015 | 21.12M |
| June 30, 2015 | -22.78M |
| March 31, 2015 | -21.43M |
| December 31, 2014 | -23.64M |
| September 30, 2014 | -21.34M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| UroGen Pharma Ltd. | -170.67M |
| MeiraGTx Holdings Plc | 10.06M |
| Regeneron Pharmaceuticals, Inc. | 3.575B |
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| MacroGenics, Inc. | -65.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -55.66M |
| Cash from Investing (Quarterly) | 85.12M |
| Cash from Financing (Quarterly) | 1.031M |
| Free Cash Flow Per Share (Quarterly) | -0.7408 |
| Free Cash Flow to Equity (Quarterly) | -51.14M |
| Free Cash Flow to Firm (Quarterly) | -48.91M |
| Free Cash Flow Yield | -11.23% |